Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Clinical data on tirzepatide in type 2 diabetesthe SURPASS clinical trial program Early clinical studies with tirzepatide revealed a marked and dose-dependent reduction of HbA1c and further glycemic parameters in patients with T2D in various ethnic cohorts (clinical trials registration numbers NCT03322631, NCT03131687, and NCT03311724) (6668)
These benefits are often seen as a result of the weight loss and metabolic improvements achieved through GLP-1 medications for diabetes
Applying patches to skin that is damp, oily, or covered with lotion creates a barrier that prevents proper contact and may lead to premature detachment or inconsistent medication delivery
Originally designed for people with type 2 diabetes, Mounjaro has since shown impressive effects on weight loss and blood glucose control, particularly for those living with obesity
